Tenaya Therapeutics, Inc. Accrued Income Taxes
Tenaya Therapeutics, Inc. (TNYA) had Accrued Income Taxes of $529.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Liabilities › Accrued Liabilities
us-gaap:AccruedIncomeTaxes · last filed 2026-08-05
- 2026-06-30: Accrued Income Taxes $529.00K.
- 2026-03-31: Accrued Income Taxes $406.00K.
- 2025-12-31: Accrued Income Taxes $277.00K.
- 2024-12-31: Accrued Income Taxes $348.00K.
| Period end | Accrued Income Taxes |
|---|---|
| 2026-06-30 | $529.00K 10-Q · filed 2026-08-05 |
| 2026-03-31 | $406.00K 10-Q · filed 2026-05-06 |
| 2025-12-31 | $277.00K 10-Q · filed 2026-08-05 |
| 2024-12-31 | $348.00K 10-K · filed 2026-03-11 |
| 2024-09-30 | $202.00K 10-Q · filed 2024-11-06 |
| 2024-06-30 | $836.00K 10-Q · filed 2024-08-08 |
| 2023-12-31 | $280.00K 10-K · filed 2025-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |